Low-moderate arsenic exposure and respiratory in American Indian communities in the Strong Heart Study.


Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
28 11 2019
Historique:
received: 17 04 2019
accepted: 28 10 2019
entrez: 30 11 2019
pubmed: 30 11 2019
medline: 9 4 2020
Statut: epublish

Résumé

Arsenic exposure through drinking water is an established lung carcinogen. Evidence on non-malignant lung outcomes is less conclusive and suggests arsenic is associated with lower lung function. Studies examining low-moderate arsenic (< 50 μg/L), the level relevant for most populations, are limited. We evaluated the association of arsenic exposure with respiratory health in American Indians from the Northern Plains, the Southern Plains and the Southwest United States, communities with environmental exposure to inorganic arsenic through drinking water. The Strong Heart Study is a prospective study of American Indian adults. This analysis used urinary arsenic measurements at baseline (1989-1991) and spirometry at Visit 2 (1993-1995) from 2132 participants to evaluate associations of arsenic exposure with airflow obstruction, restrictive pattern, self-reported respiratory disease, and symptoms. Airflow obstruction was present in 21.5% and restrictive pattern was present in 14.4%. The odds ratio (95% confidence interval) for obstruction and restrictive patterns, based on the fixed ratio definition, comparing the 75th to 25th percentile of arsenic, was 1.17 (0.99, 1.38) and 1.27 (1.01, 1.60), respectively, after adjustments, and 1.28 (1.02, 1.60) and 1.33 (0.90, 1.50), respectively, based on the lower limit of normal definition. Arsenic was associated with lower percent predicted FEV1 and FVC, self-reported emphysema and stopping for breath. Low-moderate arsenic exposure was positively associated with restrictive pattern, airflow obstruction, lower lung function, self-reported emphysema and stopping for breath, independent of smoking and other lung disease risk factors. Findings suggest that low-moderate arsenic exposure may contribute to restrictive lung disease.

Sections du résumé

BACKGROUND
Arsenic exposure through drinking water is an established lung carcinogen. Evidence on non-malignant lung outcomes is less conclusive and suggests arsenic is associated with lower lung function. Studies examining low-moderate arsenic (< 50 μg/L), the level relevant for most populations, are limited. We evaluated the association of arsenic exposure with respiratory health in American Indians from the Northern Plains, the Southern Plains and the Southwest United States, communities with environmental exposure to inorganic arsenic through drinking water.
METHODS
The Strong Heart Study is a prospective study of American Indian adults. This analysis used urinary arsenic measurements at baseline (1989-1991) and spirometry at Visit 2 (1993-1995) from 2132 participants to evaluate associations of arsenic exposure with airflow obstruction, restrictive pattern, self-reported respiratory disease, and symptoms.
RESULTS
Airflow obstruction was present in 21.5% and restrictive pattern was present in 14.4%. The odds ratio (95% confidence interval) for obstruction and restrictive patterns, based on the fixed ratio definition, comparing the 75th to 25th percentile of arsenic, was 1.17 (0.99, 1.38) and 1.27 (1.01, 1.60), respectively, after adjustments, and 1.28 (1.02, 1.60) and 1.33 (0.90, 1.50), respectively, based on the lower limit of normal definition. Arsenic was associated with lower percent predicted FEV1 and FVC, self-reported emphysema and stopping for breath.
CONCLUSION
Low-moderate arsenic exposure was positively associated with restrictive pattern, airflow obstruction, lower lung function, self-reported emphysema and stopping for breath, independent of smoking and other lung disease risk factors. Findings suggest that low-moderate arsenic exposure may contribute to restrictive lung disease.

Identifiants

pubmed: 31779614
doi: 10.1186/s12940-019-0539-6
pii: 10.1186/s12940-019-0539-6
pmc: PMC6883619
doi:

Substances chimiques

Arsenicals 0
Drinking Water 0
Water Pollutants, Chemical 0
Arsenic N712M78A8G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Subventions

Organisme : NIEHS NIH HHS
ID : P42ES010349
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025216
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001409
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01ES025216
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01HL109315, R01HL109301, R01HL109284, R01HL109282 and R01HL109319 and R01HL090863
Pays : United States
Organisme : NIEHS NIH HHS
ID : F31ES028597
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES009089
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025135
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01ES021367
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

Lancet. 2007 Sep 1;370(9589):765-73
pubmed: 17765526
Am Indian Alsk Native Ment Health Res. 2000;9(3):20-37
pubmed: 11279560
Chest. 2001 Aug;120(2):489-95
pubmed: 11502648
Toxicol Appl Pharmacol. 2015 Sep 1;287(2):161-167
pubmed: 26048584
Int J Epidemiol. 2006 Aug;35(4):1001-8
pubmed: 16554379
PLoS One. 2013 Dec 06;8(12):e82970
pubmed: 24349408
Int Arch Occup Environ Health. 2011 Aug;84(6):591-600
pubmed: 20972800
J Expo Sci Environ Epidemiol. 2009 May;19(4):343-8
pubmed: 19190673
Am J Epidemiol. 2005 Sep 15;162(6):533-41
pubmed: 16093295
Diabetes Care. 2011 Oct;34(10):2306-13
pubmed: 21852681
Environ Health. 2013 Sep 02;12(1):73
pubmed: 24004508
Curr Environ Health Rep. 2016 Mar;3(1):1-12
pubmed: 26875182
Environ Health Perspect. 2006 Aug;114(8):1293-6
pubmed: 16882542
Am J Respir Crit Care Med. 2008 Feb 1;177(3):253-60
pubmed: 18006882
Environ Res. 2016 May;147:537-55
pubmed: 26891939
Curr Environ Health Rep. 2018 Jun;5(2):244-254
pubmed: 29637476
N Engl J Med. 1994 Jul 7;331(1):25-30
pubmed: 8202099
Int J Environ Health Res. 2002 Jun;12(2):175-9
pubmed: 12400554
Soc Psychiatry Psychiatr Epidemiol. 2005 Apr;40(4):291-9
pubmed: 15834780
Environ Res. 2015 Oct;142:273-80
pubmed: 26186135
Ann Intern Med. 1999 Mar 16;130(6):461-70
pubmed: 10075613
Respir Med. 2011 Jun;105(6):907-15
pubmed: 21295958
Am J Epidemiol. 1990 Dec;132(6):1141-55
pubmed: 2260546
Environ Health Perspect. 2007 Apr;115(4):586-91
pubmed: 17450228
Anal Methods. 2012;4(2):406-413
pubmed: 22685491
Am J Epidemiol. 2012 Nov 15;176(10):865-74
pubmed: 23097256
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S169-75
pubmed: 26595735
Int J Gen Med. 2010 Oct 20;3:335-43
pubmed: 21116339
J Toxicol Environ Health A. 2011;74(11):716-27
pubmed: 21480046
Toxicol Appl Pharmacol. 2016 Dec 15;313:10-15
pubmed: 27725189
Toxicol Sci. 2007 Nov;100(1):75-87
pubmed: 17682005
J Assoc Physicians India. 2004 May;52:395-400
pubmed: 15656029
Am J Physiol Lung Cell Mol Physiol. 2008 Aug;295(2):L293-302
pubmed: 18539681
Environ Health Perspect. 2009 Sep;117(9):1428-33
pubmed: 19750109
Environ Health Perspect. 2006 May;114(5):641-8
pubmed: 16675414
Diabet Med. 2010 Sep;27(9):977-87
pubmed: 20722670
Curr Environ Health Rep. 2017 Jun;4(2):229-243
pubmed: 28488132
Eur Respir J. 2002 Nov;20(5):1117-22
pubmed: 12449163

Auteurs

Martha Powers (M)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, USA. mpower24@jhu.edu.

Tiffany R Sanchez (TR)

Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, USA.

Maria Grau-Perez (M)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, USA.

Fawn Yeh (F)

Center for American Indian Health Research, University of Oklahoma Health Sciences Center, College of Public Health, Oklahoma City, OK, USA.

Kevin A Francesconi (KA)

Institute of Chemistry - Analytical Chemistry, Graz, Austria.

Walter Goessler (W)

Institute of Chemistry - Analytical Chemistry, Graz, Austria.

Christine M George (CM)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Christopher Heaney (C)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Lyle G Best (LG)

Missouri Breaks Industries Research, Inc., Eagle Butte, SD, USA.

Jason G Umans (JG)

MedStar Health Research Institute, Hyattsville, MD, USA, Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA.

Robert H Brown (RH)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, USA.
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Ana Navas-Acien (A)

Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe St, Baltimore, MD, USA.
Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH